N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual

被引:57
作者
Bautista-Aguilera, Oscar M. [1 ]
Samadi, Abdelouahid [1 ]
Chioua, Mourad [1 ]
Nikolic, Katarina [2 ]
Filipic, Slavica [2 ]
Agbaba, Danica [2 ]
Soriano, Elena [3 ]
de Andres, Lucia [4 ]
Isabel Rodriguez-Franco, Maria [4 ]
Alcaro, Stefano [5 ]
Ramsay, Rona R. [6 ]
Ortuso, Francesco [5 ]
Yanez, Matilde [7 ]
Marco-Contelles, Jose [1 ]
机构
[1] CSIC, Lab Quim Med, IQOG, E-28006 Madrid, Spain
[2] Univ Belgrade, Fac Pharm, Inst Pharmaceut Chem, Belgrade 11000, Serbia
[3] CSIC, SEPCO, IQOG, E-28006 Madrid, Spain
[4] IQM CSIC, Inst Quim Med, Madrid 28006, Spain
[5] Magna Graecia Univ Catanzaro, Dipartimento Sci Salute, I-88100 Catanzaro, Italy
[6] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland
[7] Univ Santiago de Compostela, Dept Farmacol, Fac Farm, Santiago De Compostela 15782, Spain
关键词
ALZHEIMER DRUG CANDIDATES; SELECTIVE INHIBITORS; MAO-A; ACETYLCHOLINESTERASE INHIBITORS; ANTIOXIDANT PROPERTIES; BIOLOGICAL EVALUATION; DIRECTED LIGANDS; B INHIBITION; DISEASE; HYBRIDS;
D O I
10.1021/jm501501a
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
On the basis of N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine (II, ASS234) and QSAR predictions, in this work we have designed, synthesized, and evaluated a number of new indole derivatives from which we have identified N-methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine (2, MBA236) as a new cholinesterase and monoamine oxidase dual inhibitor.
引用
收藏
页码:10455 / 10463
页数:9
相关论文
共 56 条
[1]   Polypharmacology: Challenges and Opportunities in Drug Discovery [J].
Anighoro, Andrew ;
Bajorath, Juergen ;
Rastelli, Giulio .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (19) :7874-7887
[2]   Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease [J].
Bautista-Aguilera, Oscar M. ;
Esteban, Gerard ;
Bolea, Irene ;
Nikolic, Katarina ;
Agbaba, Danica ;
Moraleda, Ignacio ;
Iriepa, Isabel ;
Samadi, Abdelouahid ;
Soriano, Elena ;
Unzeta, Mercedes ;
Marco-Contelles, Jose .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 75 :82-95
[3]   Multipotent, Permeable Drug ASS234 Inhibits Aβ Aggregation, Possesses Antioxidant Properties and Protects from Aβ-induced Apoptosis In Vitro [J].
Bolea, Irene ;
Gella, Alejandro ;
Monjas, Leticia ;
Perez, Concepcion ;
Rodriguez-Franco, Maria Isabel ;
Marco-Contelles, Jose ;
Samadi, Abdelouahid ;
Unzeta, Mercedes .
CURRENT ALZHEIMER RESEARCH, 2013, 10 (08) :797-808
[4]   Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors [J].
Bolea, Irene ;
Gella, Alejandro ;
Unzeta, Mercedes .
JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (06) :893-902
[5]   Synthesis, Biological Evaluation, and Molecular Modeling of Donepezil and N-[(5-(Benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine Hybrids as New Multipotent Cholinesterase/Monoamine Oxidase Inhibitors for the Treatment of Alzheimer's Disease [J].
Bolea, Irene ;
Juarez-Jimenez, Jordi ;
de los Rios, Cristobal ;
Chioua, Mourad ;
Pouplana, Ramon ;
Javier Luque, F. ;
Unzeta, Mercedes ;
Marco-Contelles, Jose ;
Samadi, Abdelouahid .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (24) :8251-8270
[6]   Alzheimer Disease [J].
Castellani, Rudy J. ;
Rolston, Raj K. ;
Smith, Mark A. .
DM DISEASE-A-MONTH, 2010, 56 (09) :484-546
[7]   Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors [J].
Castro, Ana ;
Martinez, Ana .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (33) :4377-4387
[8]   Multi-target-directed ligands to combat neurodegenerative diseases [J].
Cavalli, Andrea ;
Bolognesi, Maria Laura ;
Minarini, Anna ;
Rosini, Michela ;
Tumiatti, Vincenzo ;
Recanatini, Maurizio ;
Melchiorre, Carlo .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (03) :347-372
[9]  
Copeland R., 2005, EVALUATION ENZYME IN, V1st
[10]   Wnt Signaling Pathway, a Potential Target for Alzheimer's Disease Treatment, is Activated by a Novel Multitarget Compound ASS234 [J].
del Pino, Javier ;
Ramos, Eva ;
Bautista Aguilera, Oscar M. ;
Marco-Contelles, Jose ;
Romero, Alejandro .
CNS NEUROSCIENCE & THERAPEUTICS, 2014, 20 (06) :568-570